{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:39:37Z","timestamp":1795041577577,"version":"4.10.2"},"reference-count":352,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1382, Project-ID 403224013"],"award-info":[{"award-number":["SFB1382, Project-ID 403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R01 DK136511"],"award-info":[{"award-number":["NIH R01 DK136511"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH P30 DK084567"],"award-info":[{"award-number":["NIH P30 DK084567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5P30DK132710"],"award-info":[{"award-number":["5P30DK132710"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5R01CA262424"],"award-info":[{"award-number":["5R01CA262424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DK128955"],"award-info":[{"award-number":["5R01DK128955"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The liver is a central hub in lipid, carbohydrate and protein metabolism and protects against gut-derived antigens and toxins. The etiology of liver diseases includes altered metabolism, viral infections, autoimmunity, toxins and genetic alterations. Liver-resident cells, including hepatocytes, biliary epithelial cells, endothelial cells, and hepatic stellate cells, are essential for liver function and homeostasis but may also drive the development of inflammation, fibrosis, cirrhosis and liver cancer via interactions with immune cells. This review highlights the often-underappreciated contributions of epithelial, endothelial and mesenchymal liver cells in regulating inflammation and immunity across various liver diseases, emphasizing their importance in disease onset, progression and regression. Immune cells and their mediators also play a role in stimulating liver regeneration and repair following injury. Recent findings on the bidirectional interactions between immune cells and resident liver cells provide deeper insights into the underlying pathophysiology and identify novel therapeutic targets for the treatment of liver disease.<\/jats:p>","DOI":"10.1038\/s41423-025-01313-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:19:56Z","timestamp":1751350796000},"page":"1205-1225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells"],"prefix":"10.1038","volume":"22","author":[{"given":"Enis","family":"Kostallari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-2098","authenticated-orcid":false,"given":"Robert F.","family":"Schwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-9986","authenticated-orcid":false,"given":"Adrien","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1242\/dev.121.2.439","volume":"121","author":"PH Crossley","year":"1995","unstructured":"Crossley PH, Martin GR. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development. 1995;121:439\u201351.","journal-title":"Development"},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1126\/science.284.5422.1998","volume":"284","author":"J Jung","year":"1999","unstructured":"Jung J, Zheng M, Goldfarb M, Zaret KS. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science. 1999;284:1998\u20132003.","journal-title":"Science"},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1101\/gad.904601","volume":"15","author":"JM Rossi","year":"2001","unstructured":"Rossi JM, Dunn NR, Hogan BL, Zaret KS. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev. 2001;15:1998\u20132009.","journal-title":"Genes Dev"},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ydbio.2004.01.019","volume":"268","author":"W Zhang","year":"2004","unstructured":"Zhang W, Yatskievych TA, Baker RK, Antin PB. Regulation of Hex gene expression and initial stages of avian hepatogenesis by Bmp and Fgf signaling. Dev Biol. 2004;268:312\u201326.","journal-title":"Dev Biol"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1242\/dev.001230","volume":"134","author":"VA McLin","year":"2007","unstructured":"McLin VA, Rankin SA, Zorn AM. Repression of Wnt\/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development. 2007;134:2207\u201317.","journal-title":"Development"},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.devcel.2010.01.011","volume":"18","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev Cell. 2010;18:175\u201389.","journal-title":"Dev Cell"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.devcel.2023.07.002","volume":"58","author":"L Yang","year":"2023","unstructured":"Yang L, Wang X, Yu XX, Yang L, Zhou BC, Yang J, et al. The default and directed pathways of hepatoblast differentiation involve distinct epigenomic mechanisms. Dev Cell. 2023;58:1688\u2013700.e6.","journal-title":"Dev Cell"},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.1063889","volume":"294","author":"K Matsumoto","year":"2001","unstructured":"Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science. 2001;294:559\u201363.","journal-title":"Science"},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/stem.576","volume":"29","author":"S Han","year":"2011","unstructured":"Han S, Dziedzic N, Gadue P, Keller GM, Gouon-Evans V. An endothelial cell niche induces hepatic specification through dual repression of Wnt and Notch signaling. Stem Cells. 2011;29:217\u201328.","journal-title":"Stem Cells"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hep.30524","volume":"70","author":"AC Maretti-Mira","year":"2019","unstructured":"Maretti-Mira AC, DeLeve LD. Sinusoids as drivers of liver development: more than simple chemistry. Hepatology. 2019;70:737\u20139.","journal-title":"Hepatology"},{"key":"1313_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.649937","volume":"9","author":"M Miah","year":"2021","unstructured":"Miah M, Goh I, Haniffa M. Prenatal development and function of human mononuclear phagocytes. Front Cell Dev Biol. 2021;9:649937.","journal-title":"Front Cell Dev Biol"},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-99-7471-9_1","volume":"1442","author":"S Hou","year":"2023","unstructured":"Hou S, Liu C, Yao Y, Bai Z, Gong Y, Wang C, et al. Hematopoietic stem cell development in mammalian embryos. Adv Exp Med Biol. 2023;1442:1\u201316.","journal-title":"Adv Exp Med Biol"},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.devcel.2022.01.004","volume":"57","author":"Y Liang","year":"2022","unstructured":"Liang Y, Kaneko K, Xin B, Lee J, Sun X, Zhang K, et al. Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics. Dev Cell. 2022;57:398\u2013414.e5.","journal-title":"Dev Cell"},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27:R1147\u2013R51.","journal-title":"Curr Biol"},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","volume":"3","author":"JH Tabibian","year":"2013","unstructured":"Tabibian JH, Masyuk AI, Masyuk TV, O\u2019Hara SP, LaRusso NF. Physiology of cholangiocytes. Compr Physiol. 2013;3:541\u201365.","journal-title":"Compr Physiol"},{"key":"1313_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-2001-17550","volume":"21","author":"A Geerts","year":"2001","unstructured":"Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001;21:311\u201335.","journal-title":"Semin Liver Dis"},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","volume":"1791","author":"WS Blaner","year":"2009","unstructured":"Blaner WS, O\u2019Byrne SM, Wongsiriroj N, Kluwe J, D\u2019Ambrosio DM, Jiang H, et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta. 2009;1791:467\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"1313_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100754","volume":"3","author":"S Hu","year":"2022","unstructured":"Hu S, Liu S, Bian Y, Poddar M, Singh S, Cao C, et al. Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Rep Med. 2022;3:100754.","journal-title":"Cell Rep Med"},{"key":"1313_CR19","doi-asserted-by":"crossref","unstructured":"Sugimoto A, Saito Y, Wang G, Sun Q, Yin C, Lee KH, et al. Hepatic stellate cells control liver zonation, size and functions via R-spondin 3. Nature. 2025;640:752\u201361.","DOI":"10.1038\/s41586-025-08677-w"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","volume":"55","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity. 2022;55:1515\u201329.","journal-title":"Immunity"},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"237ra66","DOI":"10.1126\/scitranslmed.3008618","volume":"6","author":"ML Balmer","year":"2014","unstructured":"Balmer ML, Slack E, de Gottardi A, Lawson MA, Hapfelmeier S, Miele L, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. 2014;6:237ra66.","journal-title":"Sci Transl Med"},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/0016-5085(89)91571-0","volume":"96","author":"ES Fox","year":"1989","unstructured":"Fox ES, Thomas P, Broitman SA. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology. 1989;96:456\u201361.","journal-title":"Gastroenterology"},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324\u201332.","journal-title":"Nat Med"},{"key":"1313_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/hep.23739","volume":"52","author":"K Jagavelu","year":"2010","unstructured":"Jagavelu K, Routray C, Shergill U, O\u2019Hara SP, Faubion W, Shah VH. Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver. Hepatology. 2010;52:590\u2013601.","journal-title":"Hepatology"},{"key":"1313_CR25","doi-asserted-by":"crossref","unstructured":"Gao H, Jiang Y, Zeng G, Huda N, Thoudam T, Yang Z, et al. Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease. eGastroenterology. 2024;2:e100104.","DOI":"10.1136\/egastro-2024-100104"},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1152\/physrev.00004.2023","volume":"105","author":"V Ronca","year":"2025","unstructured":"Ronca V, Gerussi A, Collins P, Parente A, Oo YH, Invernizzi P. The liver as a central \u201chub\u201d of the immune system: pathophysiological implications. Physiol Rev. 2025;105:493\u2013539.","journal-title":"Physiol Rev"},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.18632\/oncotarget.12275","volume":"8","author":"N Li","year":"2017","unstructured":"Li N, Hua J. Immune cells in liver regeneration. Oncotarget. 2017;8:3628\u201339.","journal-title":"Oncotarget"},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver\u2014guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","volume":"91","author":"JG Bode","year":"2012","unstructured":"Bode JG, Albrecht U, Haussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins-regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. Eur J Cell Biol. 2012;91:496\u2013505.","journal-title":"Eur J Cell Biol"},{"key":"1313_CR30","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1172\/JCI59408","volume":"122","author":"LJ Quinton","year":"2012","unstructured":"Quinton LJ, Blahna MT, Jones MR, Allen E, Ferrari JD, Hilliard KL, et al. Hepatocyte-specific mutation of both NF-kappaB RelA and STAT3 abrogates the acute phase response in mice. J Clin Invest. 2012;122:1758\u201363.","journal-title":"J Clin Invest"},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jhep.2020.09.021","volume":"74","author":"N Schumacher","year":"2021","unstructured":"Schumacher N, Yan K, Gandrass M, Muller M, Krisp C, Hasler R, et al. Cell-autonomous hepatocyte-specific GP130 signaling is sufficient to trigger a robust innate immune response in mice. J Hepatol. 2021;74:407\u201318.","journal-title":"J Hepatol"},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1515\/hsz-2021-0209","volume":"402","author":"C Ehlting","year":"2021","unstructured":"Ehlting C, Wolf SD, Bode JG. Acute-phase protein synthesis: a key feature of innate immune functions of the liver. Biol Chem. 2021;402:1129\u201345.","journal-title":"Biol Chem"},{"key":"1313_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/hep.30508","volume":"70","author":"EB Thorgersen","year":"2019","unstructured":"Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH, et al. The Role of Complement in Liver Injury, Regeneration, and Transplantation. Hepatology. 2019;70:725\u201336.","journal-title":"Hepatology"},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-3-030-41769-7_17","volume":"94","author":"GH Sack Jr","year":"2020","unstructured":"Sack GH Jr. Serum amyloid A (SAA) proteins. Subcell Biochem. 2020;94:421\u201336.","journal-title":"Subcell Biochem"},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111:1805\u201312.","journal-title":"J Clin Investig"},{"key":"1313_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1425168","volume":"15","author":"HH Zhou","year":"2024","unstructured":"Zhou HH, Tang YL, Xu TH, Cheng B. C-reactive protein: structure, function, regulation, and role in clinical diseases. Front Immunol. 2024;15:1425168.","journal-title":"Front Immunol"},{"key":"1313_CR37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"e110053","DOI":"10.1371\/journal.pone.0110053","volume":"9","author":"FM Segers","year":"2014","unstructured":"Segers FM, Verdam FJ, de Jonge C, Boonen B, Driessen A, Shiri-Sverdlov R, et al. Complement alternative pathway activation in human nonalcoholic steatohepatitis. PLoS One. 2014;9:e110053.","journal-title":"PLoS One"},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/lt.23503","volume":"18","author":"H Haugaa","year":"2012","unstructured":"Haugaa H, Thorgersen EB, Pharo A, Boberg KM, Foss A, Line PD, et al. Inflammatory markers sampled by microdialysis catheters distinguish rejection from ischemia in liver grafts. Liver Transplant. 2012;18:1421\u20139.","journal-title":"Liver Transplant"},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.12659\/AOT.905464","volume":"22","author":"MH Hussein","year":"2017","unstructured":"Hussein MH, Hashimoto T, Suzuki T, Abdel-Hamid Daoud G, Kato T, Hibi M, et al. Liver Transplantation from Female Donors Provokes Higher Complement Component C5a Activity. Ann Transpl. 2017;22:694\u2013700.","journal-title":"Ann Transpl"},{"key":"1313_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186653","volume":"14","author":"T Tajima","year":"2023","unstructured":"Tajima T, Hata K, Kusakabe J, Miyauchi H, Badshah JS, Kageyama S, et al. Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats. Front Immunol. 2023;14:1186653.","journal-title":"Front Immunol"},{"key":"1313_CR42","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/TP.0b013e31818775ca","volume":"86","author":"L Waelgaard","year":"2008","unstructured":"Waelgaard L, Thorgersen EB, Line PD, Foss A, Mollnes TE, Tonnessen TI. Microdialysis monitoring of liver grafts by metabolic parameters, cytokine production, and complement activation. Transplantation. 2008;86:1096\u2013103.","journal-title":"Transplantation"},{"key":"1313_CR43","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jcmgh.2021.01.001","volume":"11","author":"J Kusakabe","year":"2021","unstructured":"Kusakabe J, Hata K, Miyauchi H, Tajima T, Wang Y, Tamaki I, et al. Complement-5 inhibition deters progression of fulminant hepatitis to acute liver failure in murine models. Cell Mol Gastroenterol Hepatol. 2021;11:1351\u201367.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1313_CR44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20131902","volume":"211","author":"KM Marshall","year":"2014","unstructured":"Marshall KM, He S, Zhong Z, Atkinson C, Tomlinson S. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy. J Exp Med. 2014;211:1793\u2013805.","journal-title":"J Exp Med"},{"key":"1313_CR45","doi-asserted-by":"crossref","unstructured":"Li M, Kim YM, Koh JH, Park J, Kwon HM, Park JH, et al. Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5. J Clin Investig. 2024;134:e167835.","DOI":"10.1172\/JCI167835"},{"key":"1313_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbrc.2022.11.079","volume":"639","author":"K You","year":"2023","unstructured":"You K, Wang Y, Chen X, Yang Z, Chen Y, Tan S, et al. Neutralizing serum amyloid a protects against sinusoidal endothelial cell damage and platelet aggregation during acetaminophen-induced liver injury. Biochem Biophys Res Commun. 2023;639:20\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1313_CR47","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1074\/jbc.M114.635763","volume":"290","author":"YR Ji","year":"2015","unstructured":"Ji YR, Kim HJ, Bae KB, Lee S, Kim MO, Ryoo ZY. Hepatic serum amyloid A1 aggravates T-cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice. J Biol Chem. 2015;290:12804\u201311.","journal-title":"J Biol Chem"},{"key":"1313_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41590-024-01820-1","volume":"25","author":"ML Stone","year":"2024","unstructured":"Stone ML, Lee J, Lee JW, Coho H, Tariveranmoshabad M, Wattenberg MM, et al. Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins. Nat Immunol. 2024;25:755\u201363.","journal-title":"Nat Immunol"},{"key":"1313_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","volume":"567","author":"JW Lee","year":"2019","unstructured":"Lee JW, Stone ML, Porrett PM, Thomas SK, Komar CA, Li JH, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249\u201352.","journal-title":"Nature"},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1084\/jem.20091474","volume":"207","author":"LE Sander","year":"2010","unstructured":"Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010;207:1453\u201364.","journal-title":"J Exp Med"},{"key":"1313_CR51","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/9544","volume":"5","author":"MC Bickerstaff","year":"1999","unstructured":"Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 1999;5:694\u20137.","journal-title":"Nat Med"},{"key":"1313_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2025.02.008","volume":"180","author":"ZM Tang","year":"2025","unstructured":"Tang ZM, Yuan P, Gao N, Lei JG, Ahmed M, Hua YX, et al. C-reactive protein attenuates CCl(4)-induced acute liver injury by regulating complement system activation. Mol Immunol. 2025;180:44\u201354.","journal-title":"Mol Immunol"},{"key":"1313_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcmgh.2021.09.003","volume":"13","author":"HY Li","year":"2022","unstructured":"Li HY, Tang ZM, Wang Z, Lv JM, Liu XL, Liang YL, et al. C-reactive protein protects against acetaminophen-induced liver injury by preventing complement overactivation. Cell Mol Gastroenterol Hepatol. 2022;13:289\u2013307.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1313_CR54","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3892\/ijmm.2017.3028","volume":"40","author":"M Cong","year":"2017","unstructured":"Cong M, Zhao W, Liu T, Wang P, Fan X, Zhai Q, et al. Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice. Int J Mol Med. 2017;40:454\u201364.","journal-title":"Int J Mol Med"},{"key":"1313_CR55","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1016\/j.ajpath.2019.08.005","volume":"189","author":"D Pilling","year":"2019","unstructured":"Pilling D, Cox N, Thomson MA, Karhadkar TR, Gomer RH. Serum amyloid P and a dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin ligand inhibit high-fat diet-induced adipose tissue and liver inflammation and steatosis in mice. Am J Pathol. 2019;189:2400\u201313.","journal-title":"Am J Pathol"},{"key":"1313_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/liv.13264","volume":"37","author":"D Agiasotelli","year":"2017","unstructured":"Agiasotelli D, Alexopoulou A, Vasilieva L, Hadziyannis E, Goukos D, Daikos GL, et al. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int. 2017;37:576\u201382.","journal-title":"Liver Int"},{"key":"1313_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106562","volume":"187","author":"E Milbank","year":"2023","unstructured":"Milbank E, Diaz-Trelles R, Dragano N, Latorre J, Mukthavaram R, Mayneris-Perxachs J, et al. Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological nonobesogenic conditions. Pharm Res. 2023;187:106562.","journal-title":"Pharm Res"},{"key":"1313_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","volume":"1482","author":"T Fournier","year":"2000","unstructured":"Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482:157\u201371.","journal-title":"Biochim Biophys Acta"},{"key":"1313_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.686251","volume":"12","author":"M Ruiz","year":"2021","unstructured":"Ruiz M. Into the labyrinth of the lipocalin alpha1-acid glycoprotein. Front Physiol. 2021;12:686251.","journal-title":"Front Physiol"},{"key":"1313_CR60","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.3748\/wjg.v27.i45.7739","volume":"27","author":"GO Elpek","year":"2021","unstructured":"Elpek GO. Orosomucoid in liver diseases. World J Gastroenterol. 2021;27:7739\u201347.","journal-title":"World J Gastroenterol"},{"key":"1313_CR61","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3748\/wjg.v26.i8.804","volume":"26","author":"HZ Zhu","year":"2020","unstructured":"Zhu HZ, Zhou WJ, Wan YF, Ge K, Lu J, Jia CK. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer. World J Gastroenterol. 2020;26:804\u201317.","journal-title":"World J Gastroenterol"},{"key":"1313_CR62","doi-asserted-by":"crossref","unstructured":"Liu H, Yin G, Franco Leonardi B, Lan T, Ait Ahmed Y, Berger H, et al. Reactive cholangiocyte-derived ORM2 drives a pathogenic modulation of the injured biliary niche through macrophage reprogramming. Gut. 2025. Online ahead of print.","DOI":"10.1136\/gutjnl-2024-334425"},{"key":"1313_CR63","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s42255-022-00627-4","volume":"4","author":"B Zhou","year":"2022","unstructured":"Zhou B, Luo Y, Ji N, Hu C, Lu Y. Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis. Nat Metab. 2022;4:1185\u2013201.","journal-title":"Nat Metab"},{"key":"1313_CR64","doi-asserted-by":"publisher","first-page":"G1570","DOI":"10.1152\/ajpgi.00399.2006","volume":"292","author":"K Abshagen","year":"2007","unstructured":"Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B. Loss of NF-kappaB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1570\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1313_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/jhep.2002.30081","volume":"35","author":"X Aldeguer","year":"2002","unstructured":"Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X, et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology. 2002;35:40\u20138.","journal-title":"Hepatology"},{"key":"1313_CR66","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","volume":"274","author":"DE Cressman","year":"1996","unstructured":"Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996;274:1379\u201383.","journal-title":"Science"},{"key":"1313_CR67","doi-asserted-by":"publisher","first-page":"e0136774","DOI":"10.1371\/journal.pone.0136774","volume":"10","author":"K Nishiyama","year":"2015","unstructured":"Nishiyama K, Nakashima H, Ikarashi M, Kinoshita M, Nakashima M, Aosasa S, et al. Mouse CD11b+Kupffer cells recruited from bone marrow accelerate liver regeneration after partial hepatectomy. PLoS One. 2015;10:e0136774.","journal-title":"PLoS One"},{"key":"1313_CR68","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1053\/gast.2003.50098","volume":"124","author":"N Selzner","year":"2003","unstructured":"Selzner N, Selzner M, Odermatt B, Tian Y, Van Rooijen N, Clavien PA. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha\/IL-6 in mice. Gastroenterology. 2003;124:692\u2013700.","journal-title":"Gastroenterology"},{"key":"1313_CR69","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/BF02093593","volume":"41","author":"Y Shiratori","year":"1996","unstructured":"Shiratori Y, Hongo S, Hikiba Y, Ohmura K, Nagura T, Okano K, et al. Role of macrophages in regeneration of liver. Dig Dis Sci. 1996;41:1939\u201346.","journal-title":"Dig Dis Sci"},{"key":"1313_CR70","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1073\/pnas.94.4.1441","volume":"94","author":"Y Yamada","year":"1997","unstructured":"Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA. 1997;94:1441\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1313_CR71","doi-asserted-by":"crossref","unstructured":"Rigual MDM, Angulo-Aguado M, Zagorac S, Alvarez-Diaz R, Benitez-Mondejar M, Yi F, et al. Macrophages harness hepatocyte glutamate to boost liver regeneration. Nature. 2025;641:1005\u201316 .","DOI":"10.1038\/s41586-025-08778-6"},{"key":"1313_CR72","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cell.2016.03.009","volume":"165","author":"J Wang","year":"2016","unstructured":"Wang J, Kubes P. A reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair. Cell. 2016;165:668\u201378.","journal-title":"Cell"},{"key":"1313_CR73","doi-asserted-by":"publisher","first-page":"G293","DOI":"10.1152\/ajpgi.00083.2012","volume":"304","author":"S Hosoya","year":"2013","unstructured":"Hosoya S, Ikejima K, Takeda K, Arai K, Ishikawa S, Yamagata H, et al. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol. 2013;304:G293\u20139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1313_CR74","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1053\/j.gastro.2004.08.055","volume":"127","author":"R Sun","year":"2004","unstructured":"Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells\/interferon-gamma). Gastroenterology. 2004;127:1525\u201339.","journal-title":"Gastroenterology"},{"key":"1313_CR75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1053\/j.gastro.2014.04.042","volume":"147","author":"R Rao","year":"2014","unstructured":"Rao R, Graffeo CS, Gulati R, Jamal M, Narayan S, Zambirinis CP, et al. Interleukin 17-producing gammadeltaT cells promote hepatic regeneration in mice. Gastroenterology. 2014;147:473\u201384 e2.","journal-title":"Gastroenterology"},{"key":"1313_CR76","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u201333.","journal-title":"Hepatology"},{"key":"1313_CR77","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O","year":"2024","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492\u2013542.","journal-title":"J Hepatol"},{"key":"1313_CR78","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1172\/JCI91786","volume":"128","author":"C Hernandez","year":"2018","unstructured":"Hernandez C, Huebener P, Pradere JP, Antoine DJ, Friedman RA, Schwabe RF. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Investig. 2018;128:2436\u201351.","journal-title":"J Clin Investig"},{"key":"1313_CR79","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M, et al. Autoaggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH. Nature. 2021;592:444\u20139.","journal-title":"Nature"},{"key":"1313_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp8309","volume":"14","author":"H Shi","year":"2022","unstructured":"Shi H, Wang X, Li F, Gerlach BD, Yurdagul A Jr, Moore MP, et al. CD47-SIRPalpha axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Sci Transl Med. 2022;14:eabp8309.","journal-title":"Sci Transl Med"},{"key":"1313_CR81","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.24029","volume":"53","author":"M Zhang","year":"2011","unstructured":"Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-b. eta Hepatol. 2011;53:306\u201316.","journal-title":"eta Hepatol"},{"key":"1313_CR82","doi-asserted-by":"crossref","unstructured":"Mackowiak B, Fu Y, Maccioni L, Gao B. Alcohol-associated liver disease. J Clin Investig. 2024;134.","DOI":"10.1172\/JCI176345"},{"key":"1313_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.04.009","volume":"18","author":"D Feng","year":"2024","unstructured":"Feng D, Hwang S, Guillot A, Wang Y, Guan Y, Chen C, et al. Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets. Cell Mol Gastroenterol Hepatol. 2024;18:101352.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1313_CR84","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jhep.2017.06.014","volume":"67","author":"V Marin","year":"2017","unstructured":"Marin V, Poulsen K, Odena G, McMullen MR, Altamirano J, Sancho-Bru P, et al. Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients. J Hepatol. 2017;67:1018\u201325.","journal-title":"J Hepatol"},{"key":"1313_CR85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0741-8329(02)00200-8","volume":"27","author":"H Jaeschke","year":"2002","unstructured":"Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol. 2002;27:23\u20137.","journal-title":"Alcohol"},{"key":"1313_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/gutjnl-2024-332730","volume":"74","author":"H Kreimeyer","year":"2024","unstructured":"Kreimeyer H, Gonzalez CG, Fondevila MF, Hsu CL, Hartmann P, Zhang X, et al. Fecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis. Gut. 2024;74:103\u201315.","journal-title":"Gut"},{"key":"1313_CR87","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez M, Miquel R, Colmenero J, Moreno M, Garcia-Pagan JC, Bosch J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136:1639\u201350.","journal-title":"Gastroenterology"},{"key":"1313_CR88","doi-asserted-by":"crossref","unstructured":"Guan Y, Feng D, Maccioni L, Wang Y, Gao B. New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8(+) neutrophils. eGastroenterology. 2024;2:e100166.","DOI":"10.1136\/egastro-2024-100166"},{"key":"1313_CR89","doi-asserted-by":"crossref","unstructured":"Xu H, Wu Z, Qin J, Li X, Xu F, Wang W, et al. Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2. Gut. 2025. Online ahead of print.","DOI":"10.1136\/gutjnl-2024-334318"},{"key":"1313_CR90","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0168-8278(01)00276-8","volume":"36","author":"J Taieb","year":"2002","unstructured":"Taieb J, Delarche C, Paradis V, Mathurin P, Grenier A, Crestani B, et al. Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis. J Hepatol. 2002;36:342\u20138.","journal-title":"J Hepatol"},{"key":"1313_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09046-8","volume":"10","author":"W Yang","year":"2019","unstructured":"Yang W, Tao Y, Wu Y, Zhao X, Ye W, Zhao D, et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair. Nat Commun. 2019;10:1076.","journal-title":"Nat Commun"},{"key":"1313_CR92","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.3253","volume":"19","author":"SM Horner","year":"2013","unstructured":"Horner SM, Gale M Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med. 2013;19:879\u201388.","journal-title":"Nat Med"},{"key":"1313_CR93","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/hep.1840170611","volume":"17","author":"P Donaldson","year":"1993","unstructured":"Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: \u201cthe dualistic effect. Hepatology. 1993;17:1008\u201315.","journal-title":"Hepatology"},{"key":"1313_CR94","doi-asserted-by":"publisher","first-page":"16735","DOI":"10.1073\/pnas.1112251108","volume":"108","author":"Benseler","year":"2011","unstructured":"Benseler, Warren V, Vo A, Holz LE M, Tay SS, Le Couteur DG, et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci USA. 2011;108:16735\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1313_CR95","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.21378","volume":"44","author":"A Warren","year":"2006","unstructured":"Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology. 2006;44:1182\u201390.","journal-title":"Hepatology"},{"key":"1313_CR96","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.4049\/jimmunol.1900795","volume":"204","author":"BJ Burwitz","year":"2020","unstructured":"Burwitz BJ, Hashiguchi PK, Mansouri M, Meyer C, Gilbride RM, Biswas S, et al. MHC-E-restricted CD8(+) T cells target hepatitis B virus-infected human hepatocytes. J Immunol. 2020;204:2169\u201376.","journal-title":"J Immunol"},{"key":"1313_CR97","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep4.1913","volume":"6","author":"HC Xu","year":"2022","unstructured":"Xu HC, Huang J, Pandyra AA, Pandey P, Wang R, Zhang Z, et al. Single MHC-I expression promotes virus-induced liver immunopathology. Hepatol Commun. 2022;6:1620\u201333.","journal-title":"Hepatol Commun"},{"key":"1313_CR98","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","volume":"574","author":"AP Benechet","year":"2019","unstructured":"Benechet AP, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8(+) T cells undergoing hepatic priming. Nature. 2019;574:200\u20135.","journal-title":"Nature"},{"key":"1313_CR99","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/a-2365-3900","volume":"63","author":"D Wohlleber","year":"2025","unstructured":"Wohlleber D, Knolle PA. Tissue determinants of antiviral immunity in the liver. Z Gastroenterol. 2025;63:65\u201372.","journal-title":"Z Gastroenterol"},{"key":"1313_CR100","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO;2-F","volume":"28","author":"P Bertolino","year":"1998","unstructured":"Bertolino P, Trescol-Biemont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of na\u00efve CD8+ T lymphocytes but fail to promote survival. Eur J Immunol. 1998;28:221\u201336.","journal-title":"Eur J Immunol"},{"key":"1313_CR101","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1053\/j.gastro.2008.05.078","volume":"135","author":"LE Holz","year":"2008","unstructured":"Holz LE, Benseler V, Bowen DG, Bouillet P, Strasser A, O\u2019Reilly L, et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology. 2008;135:989\u201397.","journal-title":"Gastroenterology"},{"key":"1313_CR102","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.immuni.2021.05.005","volume":"54","author":"G De Simone","year":"2021","unstructured":"De Simone G, Andreata F, Bleriot C, Fumagalli V, Laura C, Garcia-Manteiga JM, et al. Identification of a Kupffer cell subset capable of reverting the T-cell dysfunction induced by hepatocellular priming. Immunity. 2021;54:2089\u2013100.e8.","journal-title":"Immunity"},{"key":"1313_CR103","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nri.2016.69","volume":"16","author":"EC Shin","year":"2016","unstructured":"Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol. 2016;16:509\u201323.","journal-title":"Nat Rev Immunol"},{"key":"1313_CR104","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.celrep.2012.08.001","volume":"2","author":"D Wohlleber","year":"2012","unstructured":"Wohlleber D, Kashkar H, Gartner K, Frings MK, Odenthal M, Hegenbarth S, et al. TNF-induced target cell killing by CTL activated through cross-presentation. Cell Rep. 2012;2:478\u201387.","journal-title":"Cell Rep"},{"key":"1313_CR105","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.2811","volume":"18","author":"S Zeissig","year":"2012","unstructured":"Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T-cell-dependent protective immunity. Nat Med. 2012;18:1060\u20138.","journal-title":"Nat Med"},{"key":"1313_CR106","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/imm.13288","volume":"162","author":"Z Lei","year":"2021","unstructured":"Lei Z, Tang R, Qi Q, Gu P, Wang J, Xu L, et al. Hepatocyte CD1d protects against liver immunopathology in mice with schistosomiasis japonica. Immunology. 2021;162:328\u201338.","journal-title":"Immunology"},{"key":"1313_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajpath.2019.09.019","volume":"190","author":"JG Lu","year":"2020","unstructured":"Lu JG, Ji P, French SW. The major histocompatibility complex class II-CD4 immunologic synapse in alcoholic hepatitis and autoimmune liver pathology: the role of aberrant major histocompatibility complex class II in hepatocytes. Am J Pathol. 2020;190:25\u201332.","journal-title":"Am J Pathol"},{"key":"1313_CR108","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3350\/cmh.2024.0060","volume":"30","author":"M Dezhbord","year":"2024","unstructured":"Dezhbord M, Kim SH, Park S, Lee DR, Kim N, Won J, et al. Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction. Clin Mol Hepatol. 2024;30:539\u201360.","journal-title":"Clin Mol Hepatol"},{"key":"1313_CR109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.alcohol.2019.08.008","volume":"84","author":"JG Lu","year":"2020","unstructured":"Lu JG, Iyasu A, French B, Tillman B, French SW. Overexpression of MHCII by hepatocytes in alcoholic hepatitis (AH) compared to nonalcoholic steatohepatitis (NASH) and normal controls. Alcohol. 2020;84:27\u201332.","journal-title":"Alcohol"},{"key":"1313_CR110","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.1840120208","volume":"12","author":"A Lobo-Yeo","year":"1990","unstructured":"Lobo-Yeo A, Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. Hepatology. 1990;12:224\u201332.","journal-title":"Hepatology"},{"key":"1313_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100576","volume":"4","author":"MTA de Beijer","year":"2022","unstructured":"de Beijer MTA, Bezstarosti K, Luijten R, Doff WAS, Boor PPC, Pieterman RFA, et al. Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma. JHEP Rep. 2022;4:100576.","journal-title":"JHEP Rep"},{"key":"1313_CR112","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805\u201320.","journal-title":"Cell"},{"key":"1313_CR113","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.virol.2022.09.011","volume":"576","author":"WJ Zhang","year":"2022","unstructured":"Zhang WJ, Li KY, Huang BH, Wang H, Wan SG, Zhou SC. The hepatocyte in the innate immunity. Virology. 2022;576:111\u20136.","journal-title":"Virology"},{"key":"1313_CR114","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","volume":"57","author":"SL Carroll","year":"2024","unstructured":"Carroll SL, Pasare C, Barton GM. Control of adaptive immunity by pattern recognition receptors. Immunity. 2024;57:632\u201348.","journal-title":"Immunity"},{"key":"1313_CR115","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1056\/NEJMra1213651","volume":"368","author":"TJ Liang","year":"2013","unstructured":"Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013;368:1907\u201317.","journal-title":"N Engl J Med"},{"key":"1313_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155952","volume":"158","author":"M Mercado-Gomez","year":"2024","unstructured":"Mercado-Gomez M, Goikoetxea-Usandizaga N, Kerbert AJC, Gracianteparaluceta LU, Serrano-Macia M, Lachiondo-Ortega S, et al. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis. Metabolism. 2024;158:155952.","journal-title":"Metabolism"},{"key":"1313_CR117","doi-asserted-by":"crossref","unstructured":"Yu J, Zhu C, Wang X, Kim K, Bartolome A, Dongiovanni P, et al. Hepatocyte TLR4 triggers interhepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis. Sci Transl Med. 2021;13:eabe1692.","DOI":"10.1126\/scitranslmed.abe1692"},{"key":"1313_CR118","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/jhep.2001.25350","volume":"34","author":"T Uesugi","year":"2001","unstructured":"Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology. 2001;34:101\u20138.","journal-title":"Hepatology"},{"key":"1313_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2024.101291","volume":"95","author":"S Fiorucci","year":"2024","unstructured":"Fiorucci S, Marchiano S, Urbani G, Di Giorgio C, Distrutti E, Zampella A, et al. Immunology of bile acids regulated receptors. Prog Lipid Res. 2024;95:101291.","journal-title":"Prog Lipid Res"},{"key":"1313_CR120","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/hep.25918","volume":"56","author":"P Borude","year":"2012","unstructured":"Borude P, Edwards G, Walesky C, Li F, Ma X, Kong B, et al. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice. Hepatology. 2012;56:2344\u201352.","journal-title":"Hepatology"},{"key":"1313_CR121","doi-asserted-by":"crossref","unstructured":"Henry Z, Meadows V, Guo GL FXR and NASH: an avenue for tissue-specific regulation. Hepatol Commun. 2023;7.","DOI":"10.1097\/HC9.0000000000000127"},{"key":"1313_CR122","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","volume":"67","author":"F Yang","year":"2007","unstructured":"Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 2007;67:863\u20137.","journal-title":"Cancer Res"},{"key":"1313_CR123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jhep.2022.01.020","volume":"77","author":"A Ghallab","year":"2022","unstructured":"Ghallab A, Hassan R, Hofmann U, Friebel A, Hobloss Z, Brackhagen L, et al. Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity. J Hepatol. 2022;77:71\u201383.","journal-title":"J Hepatol"},{"key":"1313_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.916866","volume":"13","author":"X Ye","year":"2022","unstructured":"Ye X, Zhang T, Han H. PPARalpha: a potential therapeutic target of cholestasis. Front Pharm. 2022;13:916866.","journal-title":"Front Pharm"},{"key":"1313_CR125","doi-asserted-by":"crossref","unstructured":"Li T, Hasan MN, Gu L. Bile acids regulation of cellular stress responses in liver physiology and diseases. eGastroenterology. 2024;2:e100074.","DOI":"10.1136\/egastro-2024-100074"},{"key":"1313_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05794-0","volume":"14","author":"J Hoff","year":"2023","unstructured":"Hoff J, Xiong L, Kammann T, Neugebauer S, Micheel JM, Gassler N, et al. RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis. Cell Death Dis. 2023;14:275.","journal-title":"Cell Death Dis"},{"key":"1313_CR127","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hep.32289","volume":"75","author":"J Remetic","year":"2022","unstructured":"Remetic J, Ghallab A, Hobloss Z, Brackhagen L, Hassan R, Myllys M, et al. Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance. Hepatology. 2022;75:1095\u2013109.","journal-title":"Hepatology"},{"key":"1313_CR128","doi-asserted-by":"crossref","unstructured":"Conde de la Rosa L, Fabrega L, Torres S, Nunez S, Ribas V, Segales P, et al. Stard1 promotes cholestatic liver injury and disease progression by sensitizing to bile acid hepatotoxicity. Hepatology. 2024. Online ahead of print.","DOI":"10.1097\/HEP.0000000000001184"},{"key":"1313_CR129","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1097\/HEP.0000000000000041","volume":"77","author":"L Zhang","year":"2023","unstructured":"Zhang L, Pan Q, Zhang L, Xia H, Liao J, Zhang X, et al. Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK\/STAT3 signaling. Hepatology. 2023;77:1866\u201381.","journal-title":"Hepatology"},{"key":"1313_CR130","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci S, Biagioli M, Zampella A, Distrutti E. Bile acids activated receptors regulate innate immunity. Front Immunol. 2018;9:1853.","journal-title":"Front Immunol"},{"key":"1313_CR131","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity. 2016;45:802\u201316.","journal-title":"Immunity"},{"key":"1313_CR132","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","volume":"25","author":"H Hao","year":"2017","unstructured":"Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S, et al. Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis. Cell Metab. 2017;25:856\u201367.e5.","journal-title":"Cell Metab"},{"key":"1313_CR133","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol Rev. 2021;101:683\u2013731.","journal-title":"Physiol Rev"},{"key":"1313_CR134","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1172\/JCI76289","volume":"124","author":"A Perino","year":"2014","unstructured":"Perino A, Pols TW, Nomura M, Stein S, Pellicciari R, Schoonjans K. TGR5 reduces macrophage migration through mTOR-induced C\/EBPbeta differential translation. J Clin Investig. 2014;124:5424\u201336.","journal-title":"J Clin Investig"},{"key":"1313_CR135","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581:475\u20139.","journal-title":"Nature"},{"key":"1313_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102446","volume":"15","author":"SP Singh","year":"2025","unstructured":"Singh SP, Madke T, Chand P. Global epidemiology of hepatocellular carcinoma. J Clin Exp Hepatol. 2025;15:102446.","journal-title":"J Clin Exp Hepatol"},{"key":"1313_CR137","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6.","journal-title":"Nat Rev Dis Prim"},{"key":"1313_CR138","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147:765\u201383.e4.","journal-title":"Gastroenterology"},{"key":"1313_CR139","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ccr.2009.08.021","volume":"16","author":"J Haybaeck","year":"2009","unstructured":"Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell. 2009;16:295\u2013308.","journal-title":"Cancer Cell"},{"key":"1313_CR140","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ccr.2010.03.021","volume":"17","author":"K Bettermann","year":"2010","unstructured":"Bettermann K, Vucur M, Haybaeck J, Koppe C, Janssen J, Heymann F, et al. TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell. 2010;17:481\u201396.","journal-title":"Cancer Cell"},{"key":"1313_CR141","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","volume":"11","author":"T Luedde","year":"2007","unstructured":"Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, et al. Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell. 2007;11:119\u201332.","journal-title":"Cancer Cell"},{"key":"1313_CR142","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/hep.23479","volume":"51","author":"A Weber","year":"2010","unstructured":"Weber A, Boger R, Vick B, Urbanik T, Haybaeck J, Zoller S, et al. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology. 2010;51:1226\u201336.","journal-title":"Hepatology"},{"key":"1313_CR143","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"TW Kang","year":"2011","unstructured":"Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of premalignant hepatocytes limits liver cancer development. Nature. 2011;479:547\u201351.","journal-title":"Nature"},{"key":"1313_CR144","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19:151\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"1313_CR145","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","volume":"19","author":"M Ringelhan","year":"2018","unstructured":"Ringelhan M, Pfister D, O\u2019Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222\u201332.","journal-title":"Nat Immunol"},{"key":"1313_CR146","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-024-00828-8","volume":"5","author":"L Lemaitre","year":"2024","unstructured":"Lemaitre L, Adeniji N, Suresh A, Reguram R, Zhang J, Park J, et al. Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease. Nat Cancer. 2024;5:1534\u201356.","journal-title":"Nat Cancer"},{"key":"1313_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156727","volume":"182","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang J, Chen S, Ke Y, Li Y, Chen Y. Growth differentiation factor 15: Emerging role in liver diseases. Cytokine. 2024;182:156727.","journal-title":"Cytokine"},{"key":"1313_CR148","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41586-024-08305-z","volume":"637","author":"I Melero","year":"2025","unstructured":"Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Joerger M, et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumors. Nature. 2025;637:1218\u201327.","journal-title":"Nature"},{"key":"1313_CR149","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr3026","volume":"388","author":"DK Chiu","year":"2025","unstructured":"Chiu DK, Zhang X, Cheng BY, Liu Q, Hayashi K, Yu B, et al. Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. Science. 2025;388:eadr3026.","journal-title":"Science"},{"key":"1313_CR150","doi-asserted-by":"crossref","unstructured":"Sirbe C, Simu G, Szabo I, Grama A, Pop TL. Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms. Int J Mol Sci. 2021;22:13578.","DOI":"10.3390\/ijms222413578"},{"key":"1313_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101265","volume":"7","author":"B Engel","year":"2025","unstructured":"Engel B, Assis DN, Bhat M, Clusmann J, Drenth JP, Gerussi A, et al. Quo vadis autoimmune hepatitis? - Summary of the 5(th) international autoimmune hepatitis group research workshop 2024. JHEP Rep. 2025;7:101265.","journal-title":"JHEP Rep"},{"key":"1313_CR152","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/hep.31473","volume":"73","author":"C Schultheiss","year":"2021","unstructured":"Schultheiss C, Simnica D, Willscher E, Oberle A, Fanchi L, Bonzanni N, et al. Next-generation immunosequencing reveals pathological T-cell architecture in autoimmune hepatitis. Hepatology. 2021;73:1436\u201348.","journal-title":"Hepatology"},{"key":"1313_CR153","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jhep.2020.05.053","volume":"73","author":"A Renand","year":"2020","unstructured":"Renand A, Cervera-Marzal I, Gil L, Dong C, Garcia A, Kervagoret E, et al. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. J Hepatol. 2020;73:1379\u201390.","journal-title":"J Hepatol"},{"key":"1313_CR154","doi-asserted-by":"crossref","unstructured":"Heneghan MA, Lohse AW. Update in clinical science: autoimmune hepatitis. J Hepatol. 2025;82:926\u201337.","DOI":"10.1016\/j.jhep.2024.12.041"},{"key":"1313_CR155","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol. 2019;16:269\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1313_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1192840","volume":"14","author":"X Cai","year":"2023","unstructured":"Cai X, Tacke F, Guillot A, Liu H. Cholangiokines: undervalued modulators in the hepatic microenvironment. Front Immunol. 2023;14:1192840.","journal-title":"Front Immunol"},{"key":"1313_CR157","doi-asserted-by":"crossref","unstructured":"Jalan-Sakrikar N, Guicciardi ME, O\u2019Hara SP, Azad A, LaRusso NF, Gores GJ, et al. Central role for cholangiocyte pathobiology in cholestatic liver diseases. Hepatology. 2024. Online ahead of print.","DOI":"10.1097\/HEP.0000000000001093"},{"key":"1313_CR158","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nm.2667","volume":"18","author":"L Boulter","year":"2012","unstructured":"Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012;18:572\u20139.","journal-title":"Nat Med"},{"key":"1313_CR159","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/hep4.1145","volume":"2","author":"A Guillot","year":"2018","unstructured":"Guillot A, Gasmi I, Brouillet A, Ait-Ahmed Y, Calderaro J, Ruiz I, et al. Interleukins-17 and 27 promote liver regeneration by sequentially inducing progenitor cell expansion and differentiation. Hepatol Commun. 2018;2:329\u201343.","journal-title":"Hepatol Commun"},{"key":"1313_CR160","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jhep.2019.02.003","volume":"70","author":"R Manco","year":"2019","unstructured":"Manco R, Clerbaux LA, Verhulst S, Bou Nader M, Sempoux C, Ambroise J, et al. Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury. J Hepatol. 2019;70:1180\u201391.","journal-title":"J Hepatol"},{"key":"1313_CR161","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-024-07465-2","volume":"630","author":"C Gribben","year":"2024","unstructured":"Gribben C, Galanakis V, Calderwood A, Williams EC, Chazarra-Gil R, Larraz M, et al. Acquisition of epithelial plasticity in human chronic liver disease. Nature. 2024;630:166\u201373.","journal-title":"Nature"},{"key":"1313_CR162","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/hep4.1854","volume":"6","author":"TS Andrews","year":"2022","unstructured":"Andrews TS, Atif J, Liu JC, Perciani CT, Ma XZ, Thoeni C, et al. Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity. Hepatol Commun. 2022;6:821\u201340.","journal-title":"Hepatol Commun"},{"key":"1313_CR163","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.stem.2022.04.011","volume":"29","author":"FJM Roos","year":"2022","unstructured":"Roos FJM, van Tienderen GS, Wu H, Bordeu I, Vinke D, Albarinos LM, et al. Human branching cholangiocyte organoids recapitulate functional bile duct formation. Cell Stem Cell. 2022;29:776\u201394.e13.","journal-title":"Cell Stem Cell"},{"key":"1313_CR164","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aaz6964","volume":"371","author":"F Sampaziotis","year":"2021","unstructured":"Sampaziotis F, Muraro D, Tysoe OC, Sawiak S, Beach TE, Godfrey EM, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371:839\u201346.","journal-title":"Science"},{"key":"1313_CR165","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.cell.2020.10.048","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang J, Xu Y, Chen Z, Liang J, Lin Z, Liang H, et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia. Cell. 2020;183:1867\u201383.e26.","journal-title":"Cell"},{"key":"1313_CR166","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/HEP.0000000000001064","volume":"81","author":"MH Xiao","year":"2025","unstructured":"Xiao MH, Ma D, Wu S, Huang Z, Liang P, Chen H, et al. Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia. Hepatology. 2025;81:1146\u201363.","journal-title":"Hepatology"},{"key":"1313_CR167","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1073\/pnas.1302168110","volume":"110","author":"TG Bird","year":"2013","unstructured":"Bird TG, Lu WY, Boulter L, Gordon-Keylock S, Ridgway RA, Williams MJ, et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci USA. 2013;110:6542\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1313_CR168","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1172\/JCI23486","volume":"115","author":"A Jakubowski","year":"2005","unstructured":"Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, et al. TWEAK induces liver progenitor cell proliferation. J Clin Investig. 2005;115:2330\u201340.","journal-title":"J Clin Investig"},{"key":"1313_CR169","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","volume":"90","author":"KN Lazaridis","year":"2015","unstructured":"Lazaridis KN, LaRusso NF. The cholangiopathies. Mayo Clin Proc. 2015;90:791\u2013800.","journal-title":"Mayo Clin Proc"},{"key":"1313_CR170","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41588-024-01687-w","volume":"56","author":"B Wu","year":"2024","unstructured":"Wu B, Shentu X, Nan H, Guo P, Hao S, Xu J, et al. A spatiotemporal atlas of cholestatic injury and repair in mice. Nat Genet. 2024;56:938\u201352.","journal-title":"Nat Genet"},{"key":"1313_CR171","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jhep.2021.10.009","volume":"76","author":"T Herta","year":"2022","unstructured":"Herta T, Kersten R, Chang JC, Hubers L, Go S, Tolenaars D, et al. Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection. J Hepatol. 2022;76:319\u201331.","journal-title":"J Hepatol"},{"key":"1313_CR172","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"European Association for the Study of the L","year":"2022","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022;77:761\u2013806.","journal-title":"J Hepatol"},{"key":"1313_CR173","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67:1298\u2013323.","journal-title":"J Hepatol"},{"key":"1313_CR174","doi-asserted-by":"crossref","unstructured":"Cornillet M, Geanon D, Bergquist A, Bjorkstrom NK. Immunobiology of primary sclerosing cholangitis. Hepatology. 2024. Online ahead of print.","DOI":"10.1097\/HEP.0000000000001080"},{"key":"1313_CR175","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","volume":"78","author":"A Guillot","year":"2023","unstructured":"Guillot A, Winkler M, Silva Afonso M, Aggarwal A, Lopez D, Berger H, et al. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression. Hepatology. 2023;78:150\u201366.","journal-title":"Hepatology"},{"key":"1313_CR176","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1007\/s10620-024-08570-y","volume":"69","author":"AK Frank","year":"2024","unstructured":"Frank AK, Chung BK, De Novales MLL, Engesaeter LK, Hoyle HW, Ogaard J, et al. Single-cell transcriptomic profiling of cholangiocyte organoids derived from bile ducts of primary sclerosing cholangitis patients. Dig Dis Sci. 2024;69:3810\u201323.","journal-title":"Dig Dis Sci"},{"key":"1313_CR177","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","volume":"67","author":"GM Hirschfield","year":"2018","unstructured":"Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hubscher S, et al. The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018;67:1568\u201394.","journal-title":"Gut"},{"key":"1313_CR178","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","volume":"360","author":"GM Hirschfield","year":"2009","unstructured":"Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009;360:2544\u201355.","journal-title":"N Engl J Med"},{"key":"1313_CR179","doi-asserted-by":"crossref","unstructured":"Ronca V, Davies SP, Oo YH, Lleo A. The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects. Hepatology. 2025. Online ahead of print.","DOI":"10.1097\/HEP.0000000000001225"},{"key":"1313_CR180","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","volume":"117","author":"M Leuschner","year":"1999","unstructured":"Leuschner M, Maier KP, Schlichting J, Strahl S, Herrmann G, Dahm HH, et al. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology. 1999;117:918\u201325.","journal-title":"Gastroenterology"},{"key":"1313_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53104-9","volume":"15","author":"C Jin","year":"2024","unstructured":"Jin C, Jiang P, Zhang Z, Han Y, Wen X, Zheng L, et al. Single-cell RNA sequencing reveals the pro-inflammatory roles of liver-resident Th1-like cells in primary biliary cholangitis. Nat Commun. 2024;15:8690.","journal-title":"Nat Commun"},{"key":"1313_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37213-5","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Li Z, Chen R, Lian M, Wang H, Wei Y, et al. A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression. Nat Commun. 2023;14:1732.","journal-title":"Nat Commun"},{"key":"1313_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44910-2","volume":"15","author":"SP Davies","year":"2024","unstructured":"Davies SP, Ronca V, Wootton GE, Krajewska NM, Bozward AG, Fiancette R, et al. Expression of E-cadherin by CD8(+) T cells promotes their invasion into biliary epithelial cells. Nat Commun. 2024;15:853.","journal-title":"Nat Commun"},{"key":"1313_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.sempedsurg.2025.151474","volume":"33","author":"PN Miller","year":"2024","unstructured":"Miller PN, Baskaran S, Nijagal A. Immunology of biliary atresia. Semin Pediatr Surg. 2024;33:151474.","journal-title":"Semin Pediatr Surg"},{"key":"1313_CR185","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/imcb.12366","volume":"98","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhou L, Gu G, Feng M, Ding X, Xia Q, et al. CXCL8(high) inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression. Immunol Cell Biol. 2020;98:682\u201392.","journal-title":"Immunol Cell Biol"},{"key":"1313_CR186","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/hep.30051","volume":"68","author":"J Bednarek","year":"2018","unstructured":"Bednarek J, Traxinger B, Brigham D, Roach J, Orlicky D, Wang D, et al. Cytokine-producing B cells promote immune-mediated bile duct injury in murine biliary atresia. Hepatology. 2018;68:1890\u2013904.","journal-title":"Hepatology"},{"key":"1313_CR187","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.4049\/jimmunol.1900391","volume":"204","author":"M Thapa","year":"2020","unstructured":"Thapa M, Tedesco D, Gumber S, Elrod EJ, Han JH, Kitchens WH, et al. Blockade of BAFF reshapes the hepatic B-cell receptor repertoire and attenuates autoantibody production in cholestatic liver disease. J Immunol. 2020;204:3117\u201328.","journal-title":"J Immunol"},{"key":"1313_CR188","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","volume":"77","author":"BK Chung","year":"2017","unstructured":"Chung BK, Guevel BT, Reynolds GM, Gupta Udatha DB, Henriksen EK, Stamataki Z, et al. Phenotyping and autoantibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun. 2017;77:45\u201354.","journal-title":"J Autoimmun"},{"key":"1313_CR189","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3109\/00365521.2013.786131","volume":"48","author":"L Berglin","year":"2013","unstructured":"Berglin L, Bjorkstrom NK, Bergquist A. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scand J Gastroenterol. 2013;48:719\u201328.","journal-title":"Scand J Gastroenterol"},{"key":"1313_CR190","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","volume":"79","author":"E Kotsiliti","year":"2023","unstructured":"Kotsiliti E, Leone V, Schuehle S, Govaere O, Li H, Wolf MJ, et al. Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signaling. J Hepatol. 2023;79:296\u2013313.","journal-title":"J Hepatol"},{"key":"1313_CR191","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jhep.2024.03.041","volume":"81","author":"A Bertolini","year":"2024","unstructured":"Bertolini A, Nguyen M, Zehra SA, Taleb SA, Bauer-Pisani T, Palm N, et al. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice. J Hepatol. 2024;81:429\u201340.","journal-title":"J Hepatol"},{"key":"1313_CR192","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00383-017-4154-8","volume":"33","author":"K Harada","year":"2017","unstructured":"Harada K. Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity. Pediatr Surg Int. 2017;33:1243\u20138.","journal-title":"Pediatr Surg Int"},{"key":"1313_CR193","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jhep.2022.05.044","volume":"77","author":"I Labiano","year":"2022","unstructured":"Labiano I, Agirre-Lizaso A, Olaizola P, Echebarria A, Huici-Izagirre M, Olaizola I, et al. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation. J Hepatol. 2022;77:991\u20131004.","journal-title":"J Hepatol"},{"key":"1313_CR194","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1172\/JCI73742","volume":"124","author":"J Li","year":"2014","unstructured":"Li J, Razumilava N, Gores GJ, Walters S, Mizuochi T, Mourya R, et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest. 2014;124:3241\u201351.","journal-title":"J Clin Invest"},{"key":"1313_CR195","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.1800455","volume":"203","author":"HC Jeffery","year":"2019","unstructured":"Jeffery HC, Hunter S, Humphreys EH, Bhogal R, Wawman RE, Birtwistle J, et al. Bidirectional cross-talk between biliary epithelium and Th17 cells promotes local Th17 expansion and bile duct proliferation in biliary liver diseases. J Immunol. 2019;203:1151\u20139.","journal-title":"J Immunol"},{"key":"1313_CR196","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.26598","volume":"59","author":"A Guillot","year":"2014","unstructured":"Guillot A, Hamdaoui N, Bizy A, Zoltani K, Souktani R, Zafrani ES, et al. Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver. Hepatology. 2014;59:296\u2013306.","journal-title":"Hepatology"},{"key":"1313_CR197","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143:765\u201376.e3.","journal-title":"Gastroenterology"},{"key":"1313_CR198","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/hep.26979","volume":"59","author":"CY Yang","year":"2014","unstructured":"Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP, et al. IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology. 2014;59:1944\u201353.","journal-title":"Hepatology"},{"key":"1313_CR199","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.7150\/ijbs.70408","volume":"18","author":"I Gasmi","year":"2022","unstructured":"Gasmi I, Machou C, Rodrigues A, Brouillet A, Nguyen TC, Rousseau B, et al. Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through miR-122 downregulation with increased risk of primary liver cancer initiation. Int J Biol Sci. 2022;18:1944\u201360.","journal-title":"Int J Biol Sci"},{"key":"1313_CR200","doi-asserted-by":"crossref","unstructured":"Guillot A, Guerri L, Feng D, Kim SJ, Ahmed YA, Paloczi J, et al. Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin alphavbeta6 upregulation following liver injury. J Clin Investig. 2021;131:e132305.","DOI":"10.1172\/JCI132305"},{"key":"1313_CR201","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","volume":"69","author":"ME Guicciardi","year":"2018","unstructured":"Guicciardi ME, Trussoni CE, Krishnan A, Bronk SF, Lorenzo Pisarello MJ, O\u2019Hara SP, et al. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice. J Hepatol. 2018;69:676\u201386.","journal-title":"J Hepatol"},{"key":"1313_CR202","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ncb3203","volume":"17","author":"WY Lu","year":"2015","unstructured":"Lu WY, Bird TG, Boulter L, Tsuchiya A, Cole AM, Hay T, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17:971\u201383.","journal-title":"Nat Cell Biol"},{"key":"1313_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52710-3","volume":"14","author":"A Krishnan","year":"2024","unstructured":"Krishnan A, Ozturk NB, Cutshaw KA, Guicciardi ME, Kitagataya T, Olson KE, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury. Sci Rep. 2024;14:2145.","journal-title":"Sci Rep"},{"key":"1313_CR204","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jhep.2023.05.045","volume":"79","author":"S Arino","year":"2023","unstructured":"Arino S, Aguilar-Bravo B, Coll M, Lee WY, Peiseler M, Cantallops-Vila P, et al. Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease. J Hepatol. 2023;79:1025\u201336.","journal-title":"J Hepatol"},{"key":"1313_CR205","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/path.5228","volume":"248","author":"O Govaere","year":"2019","unstructured":"Govaere O, Cockell S, Van Haele M, Wouters J, Van Delm W, Van den Eynde K, et al. High-throughput sequencing identifies etiology-dependent differences in ductular reaction in human chronic liver disease. J Pathol. 2019;248:66\u201376.","journal-title":"J Pathol"},{"key":"1313_CR206","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.26937","volume":"59","author":"VL Gadd","year":"2014","unstructured":"Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59:1393\u2013405.","journal-title":"Hepatology"},{"key":"1313_CR207","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","volume":"133","author":"MM Richardson","year":"2007","unstructured":"Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology. 2007;133:80\u201390.","journal-title":"Gastroenterology"},{"key":"1313_CR208","doi-asserted-by":"crossref","unstructured":"Paillet J, Plantureux C, Levesque S, Le Naour J, Stoll G, Sauvat A, et al. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma. J Exp Med. 2021;218:e20200853.","DOI":"10.1084\/jem.20200853"},{"key":"1313_CR209","doi-asserted-by":"publisher","first-page":"e0186643","DOI":"10.1371\/journal.pone.0186643","volume":"12","author":"JL Petrick","year":"2017","unstructured":"Petrick JL, Yang B, Altekruse SF, Van Dyke AL, Koshiol J, Graubard BI, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based study in SEER-Medicare. PLoS One. 2017;12:e0186643.","journal-title":"PLoS One"},{"key":"1313_CR210","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1313_CR211","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77:1690\u20138.","journal-title":"J Hepatol"},{"key":"1313_CR212","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1172\/JCI63212","volume":"122","author":"B Fan","year":"2012","unstructured":"Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Investig. 2012;122:2911\u20135.","journal-title":"J Clin Investig"},{"key":"1313_CR213","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1053\/j.gastro.2024.05.033","volume":"167","author":"BY Hsu","year":"2024","unstructured":"Hsu BY, Driscoll J, Human Cholangiocarcinogenesis P, Tateno C, Mattis AN, Kelley RK, et al. Human hepatocytes can give rise to intrahepatic cholangiocarcinomas. Gastroenterology. 2024;167:1029\u201332.e7.","journal-title":"Gastroenterology"},{"key":"1313_CR214","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/liv.14098","volume":"39","author":"L Fabris","year":"2019","unstructured":"Fabris L, Perugorria MJ, Mertens J, Bjorkstrom NK, Cramer T, Lleo A, et al. The tumor microenvironment and immune milieu of cholangiocarcinoma. Liver Int. 2019;39:63\u201378. Suppl 1.","journal-title":"Liver Int"},{"key":"1313_CR215","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","volume":"120","author":"B Goeppert","year":"2019","unstructured":"Goeppert B, Roessler S, Renner M, Singer S, Mehrabi A, Vogel MN, et al. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in nonliver fluke associated cholangiocarcinoma. Br J Cancer. 2019;120:109\u201314.","journal-title":"Br J Cancer"},{"key":"1313_CR216","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2249.2010.04200.x","volume":"161","author":"C Subimerb","year":"2010","unstructured":"Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, McGrath MS, et al. Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol. 2010;161:471\u20139.","journal-title":"Clin Exp Immunol"},{"key":"1313_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1453344","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang Z, Dai Y, Zhou Y, Wang Y, Chen P, Li Y, et al. Research progress of T cells in cholangiocarcinoma. Front Immunol. 2025;16:1453344.","journal-title":"Front Immunol"},{"key":"1313_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58429-7","volume":"16","author":"N Zhang","year":"2025","unstructured":"Zhang N, Sun L, Zhou S, Ji C, Cui T, Chu Q, et al. Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation. Nat Commun. 2025;16:3177.","journal-title":"Nat Commun"},{"key":"1313_CR219","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41416-022-01933-0","volume":"127","author":"A Charbel","year":"2022","unstructured":"Charbel A, Tavernar L, Albrecht T, Brinkmann F, Verheij J, Roos E, et al. Spatiotemporal analysis of tumor-infiltrating immune cells in biliary carcinogenesis. Br J Cancer. 2022;127:1603\u201314.","journal-title":"Br J Cancer"},{"key":"1313_CR220","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101230","volume":"8","author":"X Xiang","year":"2021","unstructured":"Xiang X, Liu Z, Zhang C, Li Z, Gao J, Zhang C, et al. IDH mutation subgroup status associates with intratumor heterogeneity and the tumor microenvironment in intrahepatic cholangiocarcinoma. Adv Sci. 2021;8:e2101230.","journal-title":"Adv Sci"},{"key":"1313_CR221","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"1313_CR222","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2183\/pjab.82.155","volume":"82","author":"K Wake","year":"2006","unstructured":"Wake K. Hepatic stellate cells: Three-dimensional structure, localization, heterogeneity and development. Proc Jpn Acad Ser B Phys Biol Sci. 2006;82:155\u201364.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1313_CR223","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"X Xiong","year":"2019","unstructured":"Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, et al. Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. Mol Cell. 2019;75:644\u201360.e5.","journal-title":"Mol Cell"},{"key":"1313_CR224","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A, et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022;610:356\u201365.","journal-title":"Nature"},{"key":"1313_CR225","doi-asserted-by":"crossref","unstructured":"Zhao D, Huang Z, Li X, Wang H, Hou Q, Wang Y, et al. GDF2 and BMP10 coordinate liver cellular crosstalk to maintain liver health. Elife. 2024;13:RP95811.","DOI":"10.7554\/eLife.95811.3"},{"key":"1313_CR226","doi-asserted-by":"crossref","unstructured":"Schwabe RF, Brenner DA. Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease. Nat Rev Gastroenterol Hepatol. 2025. Online ahead of print.","DOI":"10.1038\/s41575-025-01068-6"},{"key":"1313_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology. Nat Commun. 2013;4:2823.","journal-title":"Nat Commun"},{"key":"1313_CR228","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1313_CR229","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","volume":"121","author":"MA Karsdal","year":"2017","unstructured":"Karsdal MA, Nielsen SH, Leeming DJ, Langholm LL, Nielsen MJ, Manon-Jensen T, et al. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Adv Drug Deliv Rev. 2017;121:43\u201356.","journal-title":"Adv Drug Deliv Rev"},{"key":"1313_CR230","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209\u201318.","journal-title":"J Clin Investig"},{"key":"1313_CR231","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jhep.2020.04.044","volume":"73","author":"J Gao","year":"2020","unstructured":"Gao J, Wei B, de Assuncao TM, Liu Z, Hu X, Ibrahim S, et al. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol. 2020;73:1144\u201354.","journal-title":"J Hepatol"},{"key":"1313_CR232","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn5228","volume":"10","author":"S Khanal","year":"2024","unstructured":"Khanal S, Liu Y, Bamidele AO, Wixom AQ, Washington AM, Jalan-Sakrikar N, et al. Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis. Sci Adv. 2024;10:eadn5228.","journal-title":"Sci Adv"},{"key":"1313_CR233","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/hep.29803","volume":"68","author":"E Kostallari","year":"2018","unstructured":"Kostallari E, Hirsova P, Prasnicka A, Verma VK, Yaqoob U, Wongjarupong N, et al. Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2. Hepatology. 2018;68:333\u201348.","journal-title":"Hepatology"},{"key":"1313_CR234","doi-asserted-by":"crossref","unstructured":"Carter JK, Tsai MC, Venturini N, Hu J, Lemasters JJ, Torres Martin M, et al. Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction. Hepatology. 2024;80:566\u201377.","DOI":"10.1097\/HEP.0000000000000782"},{"key":"1313_CR235","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cld.2006.08.017","volume":"10","author":"DC Rockey","year":"2006","unstructured":"Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis. 2006;10:459\u201379. vii-viii.","journal-title":"Clin Liver Dis"},{"key":"1313_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.867940","volume":"13","author":"JK Carter","year":"2022","unstructured":"Carter JK, Friedman SL. Hepatic stellate cell-immune interactions in NASH. Front Endocrinol. 2022;13:867940.","journal-title":"Front Endocrinol"},{"key":"1313_CR237","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61:1066\u201379.","journal-title":"Hepatology"},{"key":"1313_CR238","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","volume":"58","author":"JP Pradere","year":"2013","unstructured":"Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. 2013;58:1461\u201373.","journal-title":"Hepatology"},{"key":"1313_CR239","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115:56\u201365.","journal-title":"J Clin Invest"},{"key":"1313_CR240","doi-asserted-by":"publisher","first-page":"G200","DOI":"10.1152\/ajpgi.2001.281.1.G200","volume":"281","author":"CA Rivera","year":"2001","unstructured":"Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR, et al. Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am J Physiol Gastrointest Liver Physiol. 2001;281:G200\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1313_CR241","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp4726","volume":"10","author":"M Ezzo","year":"2024","unstructured":"Ezzo M, Spindler K, Wang JB, Lee D, Pecoraro G, Cowen J, et al. Acute contact with profibrotic macrophages mechanically activates fibroblasts via alphavbeta3 integrin-mediated engagement of Piezo1. Sci Adv. 2024;10:eadp4726.","journal-title":"Sci Adv"},{"key":"1313_CR242","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T McHedlidze","year":"2013","unstructured":"McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity. 2013;39:357\u201371.","journal-title":"Immunity"},{"key":"1313_CR243","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1172\/JCI24798","volume":"115","author":"TI Novobrantseva","year":"2005","unstructured":"Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S, et al. Attenuated liver fibrosis in the absence of B cells. J Clin Investig. 2005;115:3072\u201382.","journal-title":"J Clin Investig"},{"key":"1313_CR244","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/hep.29636","volume":"67","author":"F Faggioli","year":"2018","unstructured":"Faggioli F, Palagano E, Di Tommaso L, Donadon M, Marrella V, Recordati C, et al. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury. Hepatology. 2018;67:1970\u201385.","journal-title":"Hepatology"},{"key":"1313_CR245","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","volume":"57","author":"TM Savage","year":"2024","unstructured":"Savage TM, Fortson KT, de Los Santos-Alexis K, Oliveras-Alsina A, Rouanne M, Rae SS, et al. Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in nonalcoholic steatohepatitis. Immunity. 2024;57:303\u201318.e6.","journal-title":"Immunity"},{"key":"1313_CR246","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M Peiseler","year":"2022","unstructured":"Peiseler M, Schwabe R, Hampe J, Kubes P, Heikenwalder M, Tacke F. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease\u2014novel insights into cellular communication circuits. J Hepatol. 2022;77:1136\u201360.","journal-title":"J Hepatol"},{"key":"1313_CR247","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006;130:435\u201352.","journal-title":"Gastroenterology"},{"key":"1313_CR248","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","volume":"27","author":"IN Crispe","year":"2009","unstructured":"Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147\u201363.","journal-title":"Annu Rev Immunol"},{"key":"1313_CR249","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.it.2016.12.006","volume":"38","author":"MN Erkelens","year":"2017","unstructured":"Erkelens MN, Mebius RE. Retinoic acid and immune homeostasis: a balancing act. Trends Immunol. 2017;38:168\u201380.","journal-title":"Trends Immunol"},{"key":"1313_CR250","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/hep.24352","volume":"54","author":"FA Schildberg","year":"2011","unstructured":"Schildberg FA, Wojtalla A, Siegmund SV, Endl E, Diehl L, Abdullah Z, et al. Murine hepatic stellate cells veto CD8 T-cell activation by a CD54-dependent mechanism. Hepatology. 2011;54:262\u201372.","journal-title":"Hepatology"},{"key":"1313_CR251","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.4049\/jimmunol.1501737","volume":"196","author":"Y Li","year":"2016","unstructured":"Li Y, Lu L, Qian S, Fung JJ, Lin F. Hepatic stellate cells directly inhibit B cells via programmed death-ligand 1. J Immunol. 2016;196:1617\u201325.","journal-title":"J Immunol"},{"key":"1313_CR252","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.20488","volume":"40","author":"MC Yu","year":"2004","unstructured":"Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ, et al. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004;40:1312\u201321.","journal-title":"Hepatology"},{"key":"1313_CR253","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","volume":"54","author":"IN Crispe","year":"2011","unstructured":"Crispe IN. Liver antigen-presenting cells. J Hepatol. 2011;54:357\u201365.","journal-title":"J Hepatol"},{"key":"1313_CR254","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.immuni.2006.11.011","volume":"26","author":"F Winau","year":"2007","unstructured":"Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, et al. Ito cells are liver-resident antigen-presenting cells for activating T-cell responses. Immunity. 2007;26:117\u201329.","journal-title":"Immunity"},{"key":"1313_CR255","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hep.24508","volume":"54","author":"MR Ebrahimkhani","year":"2011","unstructured":"Ebrahimkhani MR, Mohar I, Crispe IN. Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology. 2011;54:1379\u201387.","journal-title":"Hepatology"},{"key":"1313_CR256","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/hep.21867","volume":"46","author":"A Watanabe","year":"2007","unstructured":"Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA, et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology. 2007;46:1509\u201318.","journal-title":"Hepatology"},{"key":"1313_CR257","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/hep.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008;48:322\u201335.","journal-title":"Hepatology"},{"key":"1313_CR258","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u201397 e10.","journal-title":"Gastroenterology"},{"key":"1313_CR259","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017;65:1557\u201365.","journal-title":"Hepatology"},{"key":"1313_CR260","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"H Hagstrom","year":"2017","unstructured":"Hagstrom H, Nasr P, Ekstedt M, Hammar U, Stal P, Hultcrantz R, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67:1265\u201373.","journal-title":"J Hepatol"},{"key":"1313_CR261","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385:1559\u201369.","journal-title":"N Engl J Med"},{"key":"1313_CR262","doi-asserted-by":"crossref","unstructured":"Mehal W. Mechanisms of liver fibrosis in metabolic syndrome. eGastroenterology. 2023;1:e100015.","DOI":"10.1136\/egastro-2023-100015"},{"key":"1313_CR263","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Bonnardel J, Haest B, Vanderborght B, Wagner C, Remmerie A, et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell. 2022;185:379\u201396.e38.","journal-title":"Cell"},{"key":"1313_CR264","doi-asserted-by":"publisher","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","volume":"302","author":"K Miura","year":"2012","unstructured":"Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1310\u201321.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1313_CR265","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","volume":"15","author":"J Vonderlin","year":"2023","unstructured":"Vonderlin J, Chavakis T, Sieweke M, Tacke F. The multifaceted roles of macrophages in NAFLD pathogenesis. Cell Mol Gastroenterol Hepatol. 2023;15:1311\u201324.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1313_CR266","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20:633\u201346.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1313_CR267","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","volume":"121","author":"S Ganguly","year":"2024","unstructured":"Ganguly S, Rosenthal SB, Ishizuka K, Troutman TD, Rohm TV, Khader N, et al. Lipid-associated macrophages\u2019 promotion of fibrosis resolution during MASH regression requires TREM2. Proc Natl Acad Sci USA. 2024;121:e2405746121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1313_CR268","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.immuni.2025.01.002","volume":"58","author":"FF De Ponti","year":"2025","unstructured":"De Ponti FF, Bujko A, Liu Z, Collins PJ, Schuermans S, Maueroder C, et al. Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair. Immunity. 2025;58:362\u201380.e10.","journal-title":"Immunity"},{"key":"1313_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105905","volume":"26","author":"GG Kang","year":"2023","unstructured":"Kang GG, Trevaskis NL, Murphy AJ, Febbraio MA. Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH. iScience. 2023;26:105905.","journal-title":"iScience"},{"key":"1313_CR270","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13:412\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1313_CR271","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41591-024-03406-8","volume":"31","author":"PN Brennan","year":"2025","unstructured":"Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Troland D, et al. Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial. Nat Med. 2025;31:979\u201387.","journal-title":"Nat Med"},{"key":"1313_CR272","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA. 2012;109:E3186\u201395.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1313_CR273","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jhep.2011.10.026","volume":"56","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Iredale JP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol. 2012;56:1417\u20139.","journal-title":"J Hepatol"},{"key":"1313_CR274","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","volume":"178","author":"JA Fallowfield","year":"2007","unstructured":"Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol. 2007;178:5288\u201395.","journal-title":"J Immunol"},{"key":"1313_CR275","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1313_CR276","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598\u2013606.","journal-title":"J Hepatol"},{"key":"1313_CR277","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"1313_CR278","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S2468-1253(23)00111-5","volume":"8","author":"S Affo","year":"2023","unstructured":"Affo S, Filliol A, Gores GJ, Schwabe RF. Fibroblasts in liver cancer: functions and therapeutic translation. Lancet Gastroenterol Hepatol. 2023;8:748\u201359.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1313_CR279","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021;39:866\u201382.e11.","journal-title":"Cancer Cell"},{"key":"1313_CR280","doi-asserted-by":"crossref","unstructured":"Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Investig. 2021;131:e146987.","DOI":"10.1172\/JCI146987"},{"key":"1313_CR281","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3892\/ijo.2012.1497","volume":"41","author":"W Zhao","year":"2012","unstructured":"Zhao W, Su W, Kuang P, Zhang L, Liu J, Yin Z, et al. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma. Int J Oncol. 2012;41:457\u201364.","journal-title":"Int J Oncol"},{"key":"1313_CR282","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/ijc.25920","volume":"129","author":"W Zhao","year":"2011","unstructured":"Zhao W, Zhang L, Yin Z, Su W, Ren G, Zhou C, et al. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer. 2011;129:2651\u201361.","journal-title":"Int J Cancer"},{"key":"1313_CR283","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/labinvest.2013.139","volume":"94","author":"W Zhao","year":"2014","unstructured":"Zhao W, Zhang L, Xu Y, Zhang Z, Ren G, Tang K, et al. Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model. Lab Invest. 2014;94:182\u201391.","journal-title":"Lab Invest"},{"key":"1313_CR284","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.18632\/oncotarget.6839","volume":"7","author":"Y Xu","year":"2016","unstructured":"Xu Y, Zhao W, Xu J, Li J, Hong Z, Yin Z, et al. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2. Oncotarget. 2016;7:8866\u201378.","journal-title":"Oncotarget"},{"key":"1313_CR285","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","volume":"81","author":"J Gao","year":"2024","unstructured":"Gao J, Lan T, Kostallari E, Guo Y, Lai E, Guillot A, et al. Angiocrine signaling in sinusoidal homeostasis and liver diseases. J Hepatol. 2024;81:543\u201361.","journal-title":"J Hepatol"},{"key":"1313_CR286","doi-asserted-by":"publisher","first-page":"G246","DOI":"10.1152\/ajpgi.00118.2016","volume":"311","author":"E Kostallari","year":"2016","unstructured":"Kostallari E, Shah VH. Angiocrine signaling in the hepatic sinusoids in health and disease. Am J Physiol Gastrointest Liver Physiol. 2016;311:G246\u201351.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1313_CR287","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hep.29613","volume":"68","author":"T Leibing","year":"2018","unstructured":"Leibing T, Geraud C, Augustin I, Boutros M, Augustin HG, Okun JG, et al. Angiocrine Wnt signaling controls liver growth and metabolic maturation in mice. Hepatology. 2018;68:707\u201322.","journal-title":"Hepatology"},{"key":"1313_CR288","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.celrep.2015.10.049","volume":"13","author":"AS Rocha","year":"2015","unstructured":"Rocha AS, Vidal V, Mertz M, Kendall TJ, Charlet A, Okamoto H, et al. The angiocrine factor Rspondin3 is a key determinant of liver zonation. Cell Rep. 2015;13:1757\u201364.","journal-title":"Cell Rep"},{"key":"1313_CR289","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/a-2128-5907","volume":"43","author":"SA Cooper","year":"2023","unstructured":"Cooper SA, Kostallari E, Shah VH. Angiocrine signaling in sinusoidal health and disease. Semin Liver Dis. 2023;43:245\u201357.","journal-title":"Semin Liver Dis"},{"key":"1313_CR290","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3350\/cmh.2024.0343","volume":"30","author":"Y Iwakiri","year":"2024","unstructured":"Iwakiri Y. Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on \u201cLiver sinusoidal endothelial cell: an important yet often overlooked player in the liver fibrosis. Clin Mol Hepatol. 2024;30:673\u20136.","journal-title":"Clin Mol Hepatol"},{"key":"1313_CR291","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06318-7","volume":"9","author":"SA MacParland","year":"2018","unstructured":"MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018;9:4383.","journal-title":"Nat Commun"},{"key":"1313_CR292","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","volume":"78","author":"MJ McConnell","year":"2023","unstructured":"McConnell MJ, Kostallari E, Ibrahim SH, Iwakiri Y. The evolving role of liver sinusoidal endothelial cells in liver health and disease. Hepatology. 2023;78:649\u201369.","journal-title":"Hepatology"},{"key":"1313_CR293","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jcmgh.2020.12.007","volume":"11","author":"T Su","year":"2021","unstructured":"Su T, Yang Y, Lai S, Jeong J, Jung Y, McConnell M, et al. Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis. Cell Mol Gastroenterol Hepatol. 2021;11:1139\u201361.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1313_CR294","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3350\/cmh.2020.0179","volume":"26","author":"R Kondo","year":"2020","unstructured":"Kondo R, Iwakiri Y. The lymphatic system in alcohol-associated liver disease. Clin Mol Hepatol. 2020;26:633\u20138.","journal-title":"Clin Mol Hepatol"},{"key":"1313_CR295","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101069","volume":"6","author":"Y Yang","year":"2024","unstructured":"Yang Y, Jeong J, Su T, Lai S, Zhang P, Garcia-Milian R, et al. Interleukin-7-based identification of liver lymphatic endothelial cells reveals their unique structural features. JHEP Rep. 2024;6:101069.","journal-title":"JHEP Rep"},{"key":"1313_CR296","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3:51\u201362.","journal-title":"Nat Rev Immunol"},{"key":"1313_CR297","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3350\/cmh.2024.0734","volume":"31","author":"A Gibert-Ramos","year":"2025","unstructured":"Gibert-Ramos A, Andres-Rozas M, Pasto R, Alfaro-Retamero P, Guixe-Muntet S, Gracia-Sancho J. Sinusoidal communication in chronic liver disease. Clin Mol Hepatol. 2025;31:32\u201355.","journal-title":"Clin Mol Hepatol"},{"key":"1313_CR298","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2019.09.002","volume":"51","author":"M Sakai","year":"2019","unstructured":"Sakai M, Troutman TD, Seidman JS, Ouyang Z, Spann NJ, Abe Y, et al. Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain kupffer cell identity. Immunity. 2019;51:655\u201370.e8.","journal-title":"Immunity"},{"key":"1313_CR299","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","volume":"51","author":"J Bonnardel","year":"2019","unstructured":"Bonnardel J, T\u2019Jonck W, Gaublomme D, Browaeys R, Scott CL, Martens L, et al. Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity. 2019;51:638\u201354.e9.","journal-title":"Immunity"},{"key":"1313_CR300","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.4049\/jimmunol.1700540","volume":"200","author":"J Liu","year":"2018","unstructured":"Liu J, Yu Q, Wu W, Huang X, Broering R, Werner M, et al. TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T-Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production. J Immunol. 2018;200:2341\u201351.","journal-title":"J Immunol"},{"key":"1313_CR301","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.21965","volume":"47","author":"L Diehl","year":"2008","unstructured":"Diehl L, Schurich A, Grochtmann R, Hegenbarth S, Chen L, Knolle PA. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T-cell tolerance. Hepatology. 2008;47:296\u2013305.","journal-title":"Hepatology"},{"key":"1313_CR302","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jhep.2014.04.027","volume":"61","author":"A Carambia","year":"2014","unstructured":"Carambia A, Freund B, Schwinge D, Heine M, Laschtowitz A, Huber S, et al. TGF-beta-dependent induction of CD4(+)CD25(+)Foxp3(+) Tregs by liver sinusoidal endothelial cells. J Hepatol. 2014;61:594\u20139.","journal-title":"J Hepatol"},{"key":"1313_CR303","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2014.04.028","volume":"61","author":"K Scholzel","year":"2014","unstructured":"Scholzel K, Schildberg FA, Welz M, Borner C, Geiger S, Kurts C, et al. Transfer of MHC-class-I molecules among liver sinusoidal cells facilitates hepatic immune surveillance. J Hepatol. 2014;61:600\u20138.","journal-title":"J Hepatol"},{"key":"1313_CR304","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/hep.27376","volume":"61","author":"LD DeLeve","year":"2015","unstructured":"DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology. 2015;61:1740\u20136.","journal-title":"Hepatology"},{"key":"1313_CR305","doi-asserted-by":"crossref","unstructured":"Gan C, Yaqoob U, Lu J, Xie M, Anwar A, Jalan-Sakrikar N, et al. Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV-driven sinusoidal remodeling. JCI Insight. 2024;9:e174775.","DOI":"10.1172\/jci.insight.174775"},{"key":"1313_CR306","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jhep.2007.03.014","volume":"47","author":"J Gracia-Sancho","year":"2007","unstructured":"Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, Garcia-Caldero H, Bosch J, Garcia-Pagan JC. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. J Hepatol. 2007;47:220\u20137.","journal-title":"J Hepatol"},{"key":"1313_CR307","first-page":"336","volume":"30","author":"H Popper","year":"1963","unstructured":"Popper H, Barka T, Goldfarb S, Hutterer F, Paronetto F, Rubin E, et al. Factors determining chronicity of liver disease. a progress report. J Mt Sinai Hosp N Y. 1963;30:336\u201348.","journal-title":"J Mt Sinai Hosp N Y"},{"key":"1313_CR308","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.gastro.2019.03.013","volume":"157","author":"MB Hilscher","year":"2019","unstructured":"Hilscher MB, Sehrawat T, Arab JP, Zeng Z, Gao J, Liu M, et al. Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension. Gastroenterology. 2019;157:193\u2013209.e9.","journal-title":"Gastroenterology"},{"key":"1313_CR309","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2022.03.029","volume":"77","author":"T Greuter","year":"2022","unstructured":"Greuter T, Yaqoob U, Gan C, Jalan-Sakrikar N, Kostallari E, Lu J, et al. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J Hepatol. 2022;77:723\u201334.","journal-title":"J Hepatol"},{"key":"1313_CR310","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1002\/hep.31617","volume":"73","author":"J Gao","year":"2021","unstructured":"Gao J, Wei B, Liu M, Hirsova P, Sehrawat TS, Cao S, et al. Endothelial p300 promotes portal hypertension and hepatic fibrosis through C-C motif chemokine ligand 2-mediated angiocrine signaling. Hepatology. 2021;73:2468\u201383.","journal-title":"Hepatology"},{"key":"1313_CR311","doi-asserted-by":"crossref","unstructured":"Guan Y, Peiffer B, Feng D, Parra MA, Wang Y, Fu Y, et al. IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis. J Clin Investig. 2024;134.","DOI":"10.1172\/JCI178616"},{"key":"1313_CR312","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24843-w","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu M, Cao S, He L, Gao J, Arab JP, Cui H, et al. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis. Nat Commun. 2021;12:4560.","journal-title":"Nat Commun"},{"key":"1313_CR313","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cld.2024.06.005","volume":"28","author":"P Mandrekar","year":"2024","unstructured":"Mandrekar P, Mandal A. Pathogenesis of alcohol-associated liver disease. Clin Liver Dis. 2024;28:647\u201361.","journal-title":"Clin Liver Dis"},{"key":"1313_CR314","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pathol.2020.07.018","volume":"53","author":"P Verhaegh","year":"2021","unstructured":"Verhaegh P, Wisse E, de Munck T, Greve JW, Verheij J, Riedl R, et al. Electron microscopic observations in perfusion-fixed human nonalcoholic fatty liver disease biopsies. Pathology. 2021;53:220\u20138.","journal-title":"Pathology"},{"key":"1313_CR315","doi-asserted-by":"crossref","unstructured":"Furuta K, Guo Q, Pavelko KD, Lee JH, Robertson KD, Nakao Y, et al. Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis. J Clin Investig. 2021;131:e143690.","DOI":"10.1172\/JCI143690"},{"key":"1313_CR316","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.983255","volume":"13","author":"Q Guo","year":"2022","unstructured":"Guo Q, Furuta K, Islam S, Caporarello N, Kostallari E, Dielis K, et al. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis. Front Immunol. 2022;13:983255.","journal-title":"Front Immunol"},{"key":"1313_CR317","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101073","volume":"6","author":"M Khoury","year":"2024","unstructured":"Khoury M, Guo Q, Furuta K, Correia C, Meroueh C, Kim Lee HS, et al. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH. JHEP Rep. 2024;6:101073.","journal-title":"JHEP Rep"},{"key":"1313_CR318","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/HEP.0000000000000971","volume":"81","author":"AEC Burtis","year":"2025","unstructured":"Burtis AEC, DeNicola DMC, Ferguson ME, Santos RG, Pinilla C, Kriss MS, et al. Ag-driven CD8 + T-cell clonal expansion is a prominent feature of MASH in humans and mice. Hepatology. 2025;81:591\u2013608.","journal-title":"Hepatology"},{"key":"1313_CR319","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","volume":"161","author":"LG Guidotti","year":"2015","unstructured":"Guidotti LG, Inverso D, Sironi L, Di Lucia P, Fioravanti J, Ganzer L, et al. Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell. 2015;161:486\u2013500.","journal-title":"Cell"},{"key":"1313_CR320","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1038\/s41423-021-00769-7","volume":"18","author":"X Xie","year":"2021","unstructured":"Xie X, Luo J, Broering R, Zhu D, Zhou W, Lu M, et al. HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T-cell immunity and HBV clearance. Cell Mol Immunol. 2021;18:2572\u20134.","journal-title":"Cell Mol Immunol"},{"key":"1313_CR321","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep4.1676","volume":"5","author":"Y Du","year":"2021","unstructured":"Du Y, Yan H, Zou S, Khera T, Li J, Han M, et al. Natural killer cells regulate the maturation of liver sinusoidal endothelial cells thereby promoting intrahepatic T-cell responses in a mouse model. Hepatol Commun. 2021;5:865\u201381.","journal-title":"Hepatol Commun"},{"key":"1313_CR322","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/imm.13298","volume":"162","author":"A Carambia","year":"2021","unstructured":"Carambia A, Gottwick C, Schwinge D, Stein S, Digigow R, Seleci M, et al. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis. Immunology. 2021;162:452\u201363.","journal-title":"Immunology"},{"key":"1313_CR323","doi-asserted-by":"crossref","unstructured":"Yu M, Li X, Xu L, Zheng C, Pan W, Chen H, et al. Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease. Hepatol Commun. 2024;8:e0513.","DOI":"10.1097\/HC9.0000000000000513"},{"key":"1313_CR324","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.mn.7800204","volume":"10","author":"Y Ito","year":"2003","unstructured":"Ito Y, Bethea NW, Abril ER, McCuskey RS. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation. 2003;10:391\u2013400.","journal-title":"Microcirculation"},{"key":"1313_CR325","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hep.32787","volume":"78","author":"M Biagioli","year":"2023","unstructured":"Biagioli M, Marchiano S, di Giorgio C, Roselli R, Bordoni M, Bellini R, et al. Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury. Hepatology. 2023;78:26\u201344.","journal-title":"Hepatology"},{"key":"1313_CR326","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/hep.32256","volume":"76","author":"H Kawai","year":"2022","unstructured":"Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, et al. Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy. Hepatology. 2022;76:112\u201325.","journal-title":"Hepatology"},{"key":"1313_CR327","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/liv.12262","volume":"33","author":"C Geraud","year":"2013","unstructured":"Geraud C, Mogler C, Runge A, Evdokimov K, Lu S, Schledzewski K, et al. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumorous liver correlates with increased survival. Liver Int. 2013;33:1428\u201340.","journal-title":"Liver Int"},{"key":"1313_CR328","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1158\/0008-5472.CAN-20-3453","volume":"81","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gao Y, Du C, Markowitz GJ, Fu J, Zhang Z, et al. Hepatitis B-induced IL8 promotes hepatocellular carcinoma venous metastasis and intrahepatic treg accumulation. Cancer Res. 2021;81:2386\u201398.","journal-title":"Cancer Res"},{"key":"1313_CR329","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2024.09.044","volume":"82","author":"Y Lu","year":"2025","unstructured":"Lu Y, Liu Y, Zuo X, Li G, Wang J, Liu J, et al. CXCL12(+) tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma. J Hepatol. 2025;82:634\u201348.","journal-title":"J Hepatol"},{"key":"1313_CR330","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1497788","volume":"15","author":"KN Kremer","year":"2024","unstructured":"Kremer KN, Khammash HA, Miranda AM, Rutt LN, Twardy SM, Anton PE, et al. Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance. Front Immunol. 2024;15:1497788.","journal-title":"Front Immunol"},{"key":"1313_CR331","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01205-8","volume":"20","author":"Z Yu","year":"2022","unstructured":"Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, et al. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. J Nanobiotechnol. 2022;20:9.","journal-title":"J Nanobiotechnol"},{"key":"1313_CR332","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100524","volume":"4","author":"SJ Wallace","year":"2022","unstructured":"Wallace SJ, Tacke F, Schwabe RF, Henderson NC. Understanding the cellular interactome of nonalcoholic fatty liver disease. JHEP Rep. 2022;4:100524.","journal-title":"JHEP Rep"},{"key":"1313_CR333","doi-asserted-by":"publisher","first-page":"e000003","DOI":"10.1136\/egastro-2023-000003","volume":"1","author":"A Guillot","year":"2023","unstructured":"Guillot A, Tacke F. Spatial dimension of macrophage heterogeneity in liver diseases. eGastroenterology. 2023;1:e000003.","journal-title":"eGastroenterology"},{"key":"1313_CR334","doi-asserted-by":"crossref","unstructured":"Wen Y, Ma L, Ju C. Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases. eGastroenterology. 2023;1:e100020.","DOI":"10.1136\/egastro-2023-100020"},{"key":"1313_CR335","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512\u20138.","journal-title":"Nature"},{"key":"1313_CR336","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","volume":"631","author":"M Bosch","year":"2024","unstructured":"Bosch M, Kallin N, Donakonda S, Zhang JD, Wintersteller H, Hegenbarth S, et al. A liver immune rheostat regulates CD8 T-cell immunity in chronic HBV infection. Nature. 2024;631:867\u201375.","journal-title":"Nature"},{"key":"1313_CR337","doi-asserted-by":"crossref","unstructured":"Hong L, Mei J, Sun X, Wu Y, Dong Z, Jin Y, et al. Spatial single-cell proteomics landscape decodes the tumor microenvironmental ecosystem of intrahepatic cholangiocarcinoma. Hepatology. 2025. Online ahead of print.","DOI":"10.1097\/HEP.0000000000001283"},{"key":"1313_CR338","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101275","volume":"7","author":"Z Li","year":"2025","unstructured":"Li Z, Ma L, Chen M, Chen X, Sha M, Hang H. Single-cell analyses reveal metastasis mechanism and microenvironment remodeling of lymph node in intrahepatic cholangiocarcinoma. JHEP Rep. 2025;7:101275.","journal-title":"JHEP Rep"},{"key":"1313_CR339","doi-asserted-by":"crossref","unstructured":"Myojin Y, Babaei S, Trehan R, Hoffman C, Kedei N, Ruf B, et al. Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab. Gut. 2025. Online ahead of print.","DOI":"10.1136\/gutjnl-2024-334026"},{"key":"1313_CR340","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adq9704","volume":"9","author":"B Araujo David","year":"2024","unstructured":"Araujo David B, Atif J, Vargas ESCF, Yasmin T, Guillot A, Ait Ahmed Y, et al. Kupffer cell reverse migration into the liver sinusoids mitigates neonatal sepsis and meningitis. Sci Immunol. 2024;9:eadq9704.","journal-title":"Sci Immunol"},{"key":"1313_CR341","doi-asserted-by":"crossref","unstructured":"Jia G, He P, Dai T, Goh D, Wang J, Sun M, et al. Spatial immune scoring system predicts hepatocellular carcinoma recurrence. Nature. 2025. Online ahead of print.","DOI":"10.1038\/s41586-025-08668-x"},{"key":"1313_CR342","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq5202","volume":"381","author":"M Peiseler","year":"2023","unstructured":"Peiseler M, Araujo David B, Zindel J, Surewaard BGJ, Lee WY, Heymann F, et al. Kupffer cell-like syncytia replenish resident macrophage function in the fibrotic liver. Science. 2023;381:eabq5202.","journal-title":"Science"},{"key":"1313_CR343","doi-asserted-by":"crossref","unstructured":"Guillot A, Kohlhepp MS, Bruneau A, Heymann F, Tacke F. Deciphering the immune microenvironment on A single archival formalin-fixed paraffin-embedded tissue section by an immediately implementable multiplex fluorescence immunostaining protocol. Cancers. 2020;12:2449.","DOI":"10.3390\/cancers12092449"},{"key":"1313_CR344","doi-asserted-by":"crossref","unstructured":"Feng D, Xiang X, Guan Y, Guillot A, Lu H, Chang C, et al. Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models. J Clin Investig. 2023;133:e166954.","DOI":"10.1172\/JCI166954"},{"key":"1313_CR345","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1017\/S2633903X24000138","volume":"4","author":"MM Bolognesi","year":"2024","unstructured":"Bolognesi MM, Dall\u2019Olio L, Maerten A, Borghesi S, Castellani G, Cattoretti G. Seeing or believing in hyperplexed spatial proteomics via antibodies: new and old biases for an image-based technology. Biol Imaging. 2024;4:e10.","journal-title":"Biol Imaging"},{"key":"1313_CR346","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101209","volume":"6","author":"L Zigutyte","year":"2024","unstructured":"Zigutyte L, Sorz-Nechay T, Clusmann J, Kather JN. Use of artificial intelligence for liver diseases: a survey from the EASL congress 2024. JHEP Rep. 2024;6:101209.","journal-title":"JHEP Rep"},{"key":"1313_CR347","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jcmgh.2023.01.014","volume":"15","author":"M Rezvani","year":"2023","unstructured":"Rezvani M, Vallier L, Guillot A. Modeling nonalcoholic fatty liver disease in the dish using human-specific platforms: strategies and limitations. Cell Mol Gastroenterol Hepatol. 2023;15:1135\u201345.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1313_CR348","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160:299\u2013312.","journal-title":"Cell"},{"key":"1313_CR349","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2024.102257","volume":"89","author":"C Frau","year":"2024","unstructured":"Frau C, Vallier L. Exploiting the plasticity of cholangiocytes to repair the biliary tree. Curr Opin Genet Dev. 2024;89:102257.","journal-title":"Curr Opin Genet Dev"},{"key":"1313_CR350","doi-asserted-by":"crossref","unstructured":"Rezvani M, Lewis K, Quach S, Iwasawa K, Weihs J, Reza H, et al. Fetal liver-like organoids recapitulate blood-liver niche development and multipotent hematopoiesis from human pluripotent stem cells. bioRxiv. 2024. Online ahead of print.","DOI":"10.1101\/2024.10.11.617794"},{"key":"1313_CR351","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403516","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Yin G, Kohlhepp MS, Schumacher F, Hundertmark J, Hassan MIA, et al. Dissecting acute drug-induced hepatotoxicity and therapeutic responses of steatotic liver disease using primary mouse liver and blood cells in a liver-on-a-chip model. Adv Sci. 2024;11:e2403516.","journal-title":"Adv Sci"},{"key":"1313_CR352","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-cellbio-120420-113830","volume":"39","author":"M Adler","year":"2023","unstructured":"Adler M, Chavan AR, Medzhitov R. Tissue biology: in search of a new paradigm. Annu Rev Cell Dev Biol. 2023;39:67\u201389.","journal-title":"Annu Rev Cell Dev Biol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01313-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:02:56Z","timestamp":1759183376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01313-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":352,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01313-7","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}